In 2012, sales of the company Planmeca increased by more than 30%

Finnish manufacturer of dental equipment company Planmeca, delivers three digital educational complex for the College of Dentistry at the University of King Saud and health management of the National Guard of Saudi Arabia, in the ongoing in Saudi Arabia, large-scale measures to promote health and investment in education.

This is a major agreement for delivery of "turnkey" complex, including more than 1,000 dental units, simulation setup, two-and three-dimensional X-ray systems, as well as innovative software platform to seamlessly integrate our equipment and solutions from other companies in comfortable environment for high-tech training dentists. A similar complex with 127 dental units and a complete set of image processing systems and training systems, supplied the University of Eastern Finland in Kuopio.

A unique solution developed by Planmeca dental schools, is used in many of the leading educational institutions of the region in the world. According to Mr. Heikki Kiostilla (Heikki Kyöstilä), president of Planmeca Oy, in 2012, sales of the company Planmeca increased by more than 30%, except for the agreements with universities.

"Our success proves that universities appreciated leadership of our company in the field of technology, and orientation of the user in product development. We are very pleased to be working with these prestigious institutions. Planmeca competitive advantage achieved through significant investment in research and development activities carried out by the company, as well as through collaboration with leading research institutions, and strong business partners, "- said Heikki Kiostilla.

mednewspro
med news pro

Nosocomial infections: problems and solutions

In Manila (Philippines) held a working meeting of the APEC economic impact of hospital-acquired infections (HAI). The company BD (Becton, Dickinson and Company), applying its expertise, resources and technology to prevent the spread of infections associated with health care, throughout the world, has become one of the most active participants.

The forum was attended by representatives of the WHO, the International Consortium for the control of nosocomial infection (International Nosocomial Infections Control Consortium INICC), the Centers for Disease Control and Prevention (Centers for Disease Control and Prevention, CDC), and public health authorities in different countries and professional the medical community. The Russian delegation was represented by leading experts in the country HAI: chief physician FGBU "CDC Polyclinic" Office of the President of the Russian Federation, GA Ivanov, MD, PhD, director of the Institute of Antimicrobial Chemotherapy GBOU VPO "Smolensk State Medical Academy" of the Ministry of Health of the Russian Federation, RS Kozlov.

APEC health ministers recognize the growing economic impact caused by infectious diseases, which are becoming more prevalent in developing countries. The forum focused on the issue special panel discussions and roundtables. HAI is a serious burden and significant economic impacts on patients and health systems around the world. Out of every 100 hospitalized patients, at least 7 in developed and 10 in developing countries are infected. According to WHO, in intensive care, this figure could approach 30%.

The forum participants noted that infections acquired in the course of treatment, is one of the most common causes of death and increased mortality in hospitalized patients, to identify urgent measures to address the problem of HAI. Among them, in particular, the development of programs to improve the situation in APEC economies.

Given that most of these infections are treatable and Prevention, the workshop signed a resolution in which APEC countries reaffirm their commitment to prevent the spread of nosocomial infections. "Workable system requires active management of HAI legislative, supervisory and regulatory involvement of the state in the face of official national and regional health authorities, the active position of managerial Institutes of Health, skills, feedback mechanisms (LPU-MOH), the availability of trained personnel in the state of health care facilities (epidemiology), Resourcing, "- said Georgi Ivanov, chief medical FGBU" CDC Polyclinic "Office of the President of Russia.

Particular emphasis was placed on the role of health professionals in the prevention of nosocomial infections. This problem was given to the head of the company's BD in Russia and the CIS, MD Alexei beaver. "In order to effectively limit the spread of nosocomial infections and to reduce the associated economic costs necessary to implement the broad practice of modern biomedical technology, especially in matters of health facility staff hand hygiene, and safety of injections and other invasive clinical procedures," - he said.


med-news-pro.blogspot.com   med-news-pro.blogspot.

Pfizer has filed papers for an IPO business for the production of drugs for animals

The largest pharmaceutical company in the world - the U.S. Pfizer Inc. - Documents filed with the Commission on Securities and Exchange Commission (SEC) to conduct an initial public offering of its units, producing veterinary drugs for animals, the company said.

Underwriters of the sale of 20 per cent stake in the company, which will be called Zoetis Inc., Made by JPMorgan Chase & Co., Bank of America Corp. and Morgan Stanley.

The deal is scheduled for the first half of next year.

Revenues for the division last year was $ 4.23 billion

Pfizer intends to focus its activities on the key to its pharma business, within the framework of this strategy in April, the company sold the Swiss Nestle SA for $ 11.9 billion his unit for the production of food for children.

Found a way to grow heart muscle cells from the blood

Stem Cell Research Group at the University of California at Los Angeles (UCLA) found a surprising plasticity of embryonic endothelium. Scientists have found that the absence of a transcription factor, allows the cells to progenitors that normally produce blood stem cells and progenitor cells in the hematopoietic organs to differentiate into cardiomyocytes. The results of a two-year study were published in the journal Cell.

To determine which genes are working in the embryonic endothelium, microarray technology was used, which revealed that in the absence of Scl, one of the factors of cell differentiation, rather than genes, aimed at forming a blood stem cells are activated genes that are required for the production of cardiomyocytes. The researchers cultured embryonic yolk sac, which was absent Scl, and received by 4:00 cardiomyocytes are capable of contraction. The same potential has been detected in the endocardium Scl-deficient embryos. Scientists have tried to identify the potential to become endothelial and other related tissues such as skeletal muscle, bone or kidney, but the evidence of such plasticity could not be found.

"If you remove just one factor, Scl, the microenvironment of fetal blood vessels, usually giving rise to blood cells, begins to produce cardiomyocytes, hematopoietic making body in the" cardiogenic "body," - said Dr. Hanna Mikkola (Hanna Mikkola), one of the leading authors of the study.

These data were unexpected and extremely useful for the whole of regenerative medicine, since changing the view of the possibility of reprogramming cells. Usually, this process involves the addition of any factors to change cell "fate." But, apparently, the suppression of factors such as Scl, - a more secure way to push the cell to a different path of development.